Outcomes associated with corticosteroid dosage in critically ill patients with acute exacerbations of chronic obstructive pulmonary disease

American Journal of Respiratory and Critical Care Medicine

Volumn 189, Issue 9, 2014, Pages 1052-1064

  Kiser, Tyree H ^a   Allen, Richard R ^b   Valuck, Robert J ^a   Moss, Marc ^c   William Vandivier, R ^d  

^a UNIVERSITY OF COLORADO   (United States)

^b Peak Statistical Services   (United States)

^c Division of Pulmonary Sciences and Critical Care Medicine   (United States)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Antiinflammatory; Chronic lung disease; Intensive care unit

Indexed keywords

CORTICOSTEROID; INSULIN; METHYLPREDNISOLONE; ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CORTICOSTEROID THERAPY; CRITICALLY ILL PATIENT; DAY HOSPITAL; DISEASE EXACERBATION; FEMALE; HOSPITAL ADMISSION; HUMAN; INSULIN TREATMENT; INTENSIVE CARE UNIT; LENGTH OF STAY; LUNG VENTILATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYCOSIS; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL; PROPENSITY SCORE; TREATMENT OUTCOME; AGED; CRITICAL ILLNESS; DISEASE COURSE; DOSE RESPONSE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

ADRENAL CORTEX HORMONES; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; COHORT STUDIES; CRITICAL ILLNESS; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; METHYLPREDNISOLONE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHARMACOEPIDEMIOLOGY; PROPENSITY SCORE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84899881202     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201401-0058OC     Document Type: Article

References (29)

1. National Institutes of Health NHLBI. Morbidity and mortality: 2012 chartbook on cardiovascular, lung, and blood diseases. [accessed 2013 Feb 26]. Available from: http://www.nhlbi.nih.gov/resources/docs/2012-ChartBook.pdf
2. American Lung Association. Chronic obstructive pulmonary disease (COPD) fact sheet; 2013 [accessed 2013 Aug 26]. Available from: http://www.lung.org/ lung-disease/copd/resources/facts-figures/COPD-Fact-Sheet.html 3. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (updated 2013). [accessed 2013 Feb 26]. Available from: www.goldcopd.org
3. Chapman KR, Mannino DM, Soriano JB, Vermeire PA, Buist AS, Thun MJ, Connell C, Jemal A, Lee TA, Miravitlles M, et al. Epidemiology and costs of chronic obstructive pulmonary disease. EurRespir J 2006;27:188-207.
4. McGhan R, Radcliff T, Fish R, Sutherland ER, Welsh C, Make B. Predictors of rehospitalization and death after a severe exacerbation of COPD. Chest 2007;132:1748-1755.
5. Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:1418-1422.
6. Seneff MG, Wagner DP, Wagner RP, Zimmerman JE, Knaus WA. Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease. JAMA 1995;274:1852-1857.
7. Spencer S, Calverley PM, Burge PS, Jones PW. Impact of preventing exacerbations on deterioration of health status in COPD. Eur Respir J 2004;23:698-702.
8. Chandra D, Stamm JA, Taylor B, Ramos RM, Satterwhite L, Krishnan JA, Mannino D, Sciurba FC, Holgún F. Outcomes of noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease in the United States, 1998-2008. Am J Respir Crit Care Med 2012;185:152-159.
9. Aĺa I, de la Cal MA, Esteban A, Abella A, Ferrer R, Molina FJ, Torres A, Gordo F, Elizalde JJ, de Pablo R, et al. Efficacy of corticosteroid therapy in patients with an acute exacerbation of chronic obstructive pulmonary disease receiving ventilatory support. Arch Intern Med 2011;171:1939-1946.
10. Lindenauer PK, Pekow PS, Lahti MC, Lee Y, Benjamin EM, Rothberg MB. Association of corticosteroid dose and route of administration with risk of treatment failure in acute exacerbation of chronic obstructive pulmonary disease. JAMA 2010;303:2359-2367.
11. Niewoehner DE, Erbland ML, Deupree RH, Collins D, Gross NJ, Light RW, Anderson P, Morgan NA; Department of Veterans Affairs Cooperative Study Group. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. N Engl J Med 1999;340:1941-1947.
12. Cheng T, Gong Y, Guo Y, Cheng Q, Zhou M, Shi G, Wan H. Systemic corticosteroid for COPD exacerbations, whether the higher dose is better? A meta-analysis of randomized controlled trials. Clin Respir J 2013;7:305-318.
13. Niewoehner DE. Systemic corticosteroids for chronic obstructive pulmonary disease: benefits and risks. Monaldi Arch Chest Dis 1999; 54:422-426.
14. Schuetz P, Leuppi JD, Tamm M, Briel M, Bingisser R, Durring U, Muller B, Schindler C, Viatte S, Rutishauser J. Short versus conventional term glucocorticoid therapy in acute exacerbation of chronic obstructive pulmonary disease: the "REDUCE" trial. Swiss Med Wkly 2010;140:w13109.
15. Leuppi JD, Schuetz P, Bingisser R, Bodmer M, Briel M, DrescherT, Duerring U, Henzen C, Leibbrandt Y, Maier S, et al. Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. JAMA 2013;309:2223-2231.
16. Kiser TH, Allen R, Vandivier RW. Evaluation of corticosteroid use in critically ill patients with acute exacerbations of chronic obstructive pulmonary disease [abstract 54]. Crit Care Med 2012;40:15.
17. Kiser TH, Allen RR, Moss M, Valuck RJ, Vandivier RW. Corticosteroid dosage and outcomes in ICU patients with acute exacerbations of COPD [abstract 425]. Crit Care Med 2013;41:A102-A103.
18. Mercaldi CJ, Reynolds MW, Turpin RS. Methods to identify and compare parenteral nutrition administered from hospital-compounded and premixed multichamber bags in a retrospective hospital claims database. JPEN J Parenter Enteral Nutr 2012;36: 330-336.
19. Rothberg MB, Pekow PS, Lahti M, Brody O, Skiest DJ, Lindenauer PK. Antibiotic therapy and treatment failure in patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. JAMA 2010;303:2035-2042.
20. Schneeweiss S, Seeger JD, Landon J, Walker AM. Aprotinin during coronary-artery bypass grafting and risk of death. N Engl J Med 2008;358:771-783.
21. Stein BD, Bautista A, Schumock GT, Lee TA, Charbeneau JT, Lauderdale DS, Naureckas ET, Meltzer DO, Krishnan JA. The validity of International Classification of Diseases, Ninth Revision, clinical modification diagnosis codes for identifying patients hospitalized for COPD exacerbations. Chest 2012;141:87-93.
22. Schoenfeld DA, Bernard GR; ARDS Network. Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome. Crit Care Med 2002;30:1772-1777.
23. Marshall JC, Vincent JL, Guyatt G, Angus DC, Abraham E, Bernard G, Bombardier C, Calandra T, Jørgensen HS, Sylvester R, et al. Outcome measures for clinical research in sepsis: a report of the 2nd Cambridge Colloquium of the International Sepsis Forum. Crit Care Med 2005;33:1708-1716.
24. Rubenfeld GD, Angus DC, Pinsky MR, Curtis JR, Connors AF Jr, Bernard GR. Outcomes research in critical care: results of the American Thoracic Society Critical Care Assembly Workshop on Outcomes Research. The Members of the Outcomes Research Workshop. Am J Respir Crit Care Med 1999;160:358-367.
25. Abroug F, Ouanes-Besbes L, Fkih-Hassen M, Ouanes I, Ayed S, Dachraoui F, Brochard L, Elatrous S. Prednisone in COPD exacerbation requiring ventilatory support: an open-label randomised evaluation. Eur Respir J 2014;43:717-724.
26. Krishnan JA, Lindenauer PK, Au DH, Carson SS, Lee TA, McBurnie MA, Naureckas ET, Vollmer WM, Mularski RA; COPD Outcomes-based Network for Clinical Effectiveness and Research Translation. Stakeholder priorities for comparative effectiveness research in chronic obstructive pulmonary disease: a workshop report. Am J Respir Crit Care Med 2013;187:320-326.
27. Mularski RA, McBurnie MA, Lindenauer PK, Lee TA, Vollmer WM, Au DH, Carson SS, Krishnan JA; CONCERT Investigator Consortium. Comparative effectiveness research in chronic obstructive pulmonary disease. J Comp Eff Res 2012;1:71-82.
28. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R. Intensive insulin therapy in the medical ICU. N Engl J Med 2006;354:449-461.
29. Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, deBoisblanc B, Connors AF Jr, Hite RD, Harabin AL; National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006;354: 2564-2575.